---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-24-000020"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2024-04-29T23:59:59+00:00"
generated_at: "2026-06-03T05:21:20.475741+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lexicon CEO Lonnel Coats to retire effective July 7, 2024; board begins CEO search

## Summary
- Lonnel Coats notified retirement as CEO (principal executive officer) and board member, effective July 7, 2024.
- Board of directors has initiated a search for a new CEO, considering both internal and external candidates.
- No successor named; Coats continues until effective date.
- Lexicon Pharmaceuticals (LXRX) trades on Nasdaq.

## SEC filing metadata
- accession: 0001062822-24-000020
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2024-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/form8-kcoatsretirement.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-24-000020
- JSON: https://secwatch.observer/filing/0001062822-24-000020.json
- Plain text: https://secwatch.observer/filing/0001062822-24-000020.txt

## Key facts
- Executive change
  Lonnel Coats retired as Chief Executive Officer at LEXICON PHARMACEUTICALS, INC..
  - Action: retired
  - Role: Chief Executive Officer
  source text: On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm
- Executive change
  Lonnel Coats retired as Member of the Board of Directors at LEXICON PHARMACEUTICALS, INC..
  - Action: retired
  - Role: Member of the Board of Directors
  source text: On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.